BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3842627)

  • 1. Quantitative bone scintigraphy in Paget's disease treated with APD.
    Vellenga CJ; Pauwels EK; Bijvoet OL; Harinck HI; Frijlink WB
    Br J Radiol; 1985 Dec; 58(696):1165-72. PubMed ID: 3842627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scintigraphic aspects of the recurrence of treated Paget's disease of bone.
    Vellenga CJ; Pauwels EK; Bijvoet OL; Frijlink WB
    J Nucl Med; 1981 Jun; 22(6):510-7. PubMed ID: 7229723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone scintigraphy in Paget's disease treated with combined calcitonin and diphosphonate (EHDP).
    Vellenga CJ; Pauwels EK; Bijvoet OL; Hosking DJ; Frijlink WB
    Metab Bone Dis Relat Res; 1982; 4(2):103-11. PubMed ID: 6815413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiological assessment of Paget's disease of bone after treatment with the bisphosphonates EHDP and APD.
    Dodd GW; Ibbertson HK; Fraser TR; Holdaway IM; Wattie D
    Br J Radiol; 1987 Sep; 60(717):849-60. PubMed ID: 3117159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
    Jaeger P; Bischoff-Delaloye A; Burckhardt P
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of scintigraphic and roentgenologic studies in Paget's disease under treatment.
    Vellenga CJ; Pauwels EK; Bijvoet OL; Hosking DJ
    Radiol Clin (Basel); 1976; 45(2-4):292-301. PubMed ID: 821096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiological demonstration of healing in Paget's disease of bone treated with APD.
    Vellenga CJ; Mulder JD; Bijvoet OL
    Br J Radiol; 1985 Sep; 58(693):831-7. PubMed ID: 3842289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Bone Scintigraphy Results After Intravenous Zoledronate in Paget's Disease of Bone.
    Reid IR; Maslowski K
    Calcif Tissue Int; 2017 Jul; 101(1):43-49. PubMed ID: 28324123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the bisphosphonate APD in the control of Paget's bone disease.
    Mautalen CA; Gonzalez D; Ghiringhelli G
    Bone; 1985; 6(6):429-32. PubMed ID: 4096879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
    Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate.
    Schweitzer DH; Zwinderman AH; Vermeij P; Bijvoet OL; Papapoulos SE
    J Bone Miner Res; 1993 Feb; 8(2):175-82. PubMed ID: 8442435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three phase 99Tcm (V)DMSA scintigraphy in Paget's disease: an indicator of pamidronate effect.
    Kobayashi H; Shigeno C; Sakahara H; Yamamoto T; Hosono M; Fujimoto R; Konishi J
    Br J Radiol; 1997 Oct; 70(838):1056-9. PubMed ID: 9404211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment.
    Patel U; Gallacher SJ; Boyle IT; McKillop JH
    Nucl Med Commun; 1990 Nov; 11(11):747-60. PubMed ID: 2126078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse of osteoporosis circumscripta as a lytic ring after treatment of Paget's disease with intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate.
    Anderson DC; O'Driscoll JB; Buckler HM; Cantrill J; Brown JD
    Br J Radiol; 1988 Nov; 61(731):996-1001. PubMed ID: 3208019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone.
    Avramidis A; Polyzos SA; Moralidis E; Arsos G; Efstathiadou Z; Karakatsanis K; Grollios G; Kita M
    J Bone Miner Metab; 2008; 26(6):635-41. PubMed ID: 18979164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphosphonate treatment of Paget's disease.
    Finerman GA; Gonick HC; Smith RK; Mayfield JM
    Clin Orthop Relat Res; 1976 Oct; (120):115-24. PubMed ID: 975646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Paget's disease with olpadronate. Its efficacy in partial responders to oral pamidronate].
    González D; Pastrana M; Mautalen C
    Medicina (B Aires); 1997; 57 Suppl 1():25-31. PubMed ID: 9567351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone scintigraphy and radiology in Paget's disease of bone: a review.
    Vellenga CJ; Bijvoet OL; Pauwels EK
    Am J Physiol Imaging; 1988; 3(3):154-68. PubMed ID: 3056466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical feature and calcitonin therapy on Paget's disease of bone (author's transl)].
    Dokoh S; Morita R; Yamamoto I; Fukunaga M; Hamanaka D; Torizuka K
    Nihon Seikeigeka Gakkai Zasshi; 1979 Aug; 53(8):937-47. PubMed ID: 574527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between visual assessment and quantitative measurement of radioactivity on the bone scintigram in Paget's disease of bone.
    Vellenga CJ; Pauwels EK; Bijvoet OL
    Eur J Nucl Med; 1984; 9(12):533-7. PubMed ID: 6526052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.